Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Macrogenics (NASDAQ:MGNX) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 0 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $6.5, along with a high estimate of $14.00 and a low estimate of $4.00. Observing a downward trend, the current average is 7.14% lower than the prior average price target of $7.00.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Macrogenics by financial experts...
Login or create a forever free account to read this news
Sign up/Log in
